Good Lifestyle

In today's world, we expect us to be available when we need it. This state of mind certainly applies to the different drugs that we are prescribed , which can be debilitating to do without it. But now the United States is faced with a drug shortage attack, with more than 300 drugs at the end of spring, the highest number in a decade. Authorizing things, the average shortage has an impact at least half a million people, according to a office of the assistant secretary for planning and evaluation (ASPE) Report to Congress . And we were able to see several drug shortages continue in 2024.

Drug shortages "are a continuous concern in the United States", according to the Aspe report, impacting consumers via "higher costs, higher insurance premiums and unwanted health results". Beyond that, in a opinion For The New York Times ,, Emily Tucker , PHD, deputy professor of industrial engineering at Clemson University, stressed that average shortages are generally not "short", durable about 1.5 years And substitution drugs are not always the best option for patients.

According to the US Food and Drug Administration (FDA), shortages occur for a range of reasons , including "manufacturing and quality problems, delays and stopping", the agency then working with manufacturers to "prevent or reduce the impact" of gaps. However, Tucker stresses that there are underlying problems with the "fragile" generic system of drugs, which will require legislative action of the congress to correct. Meanwhile, patients have to face the current shortages, including four who could extend next year. Read the rest to find out which drugs can continue to be in ruins.

In relation: A new very effective weight loss medication strikes American pharmacies in the middle of the Ozempic shortage .

Different drug shortages to treat the hyperactivity disorder of the attention deficit (ADHD) were in progress, the FDA officially The shortage of Adderall, a common drug based on amphetamine, on October 12, 2022. In July of this year, FDA confirmed that medicines against Methylphenidate ADHD (Concerta) and Lisdexamfetamine (Vyvanse) were also in shortage .

According to Everyday Health, there are several reasons for NDDC shortage (Sometimes, just called the "shortage of Adderall"). The first is that the US Drug Enforcement Administration (DEA) has established manufacturing quotas for these drugs, which are controlled substances which have the potential for dependence and overdose. Last year, DEA analyzes have shown that there were 1 billion doses that the manufacturers could have produced but "did not send or ship".

The increase in demand for ADHD medication in recent years - as Diagnosis and treatment Disease has increased in adult men, women and adolescent girls - played a role in the shortage, as well as the softening of prescribing regulations during the COVVI -19 pandemic, Everyday Health reported.

Certain shortages of Adderall formulations have been resolved and the FDA spokesman James McKinney said every day that the whole situation could improve.

"Manufacturers work to meet demand and FDA helps everything we can do to increase supply. The supply is increasing, and the FDA continues to offer aid," he said .

According to the FDA, some of these drugs could also become available This month and early next year. However, others warn that patients with ADHD could still face a shortage in 2024 and potentially even longer.

"You are probably Look at 2025 Before it levels, " David Burke , Executive Director of Ohio Pharmacist Association, told Cleveland.com at the end of last month.

The main generic chemotherapy drugs are also in shortage, which is particularly scary for patients who are currently fighting for cancer.

According to a September 12 Press release From the White House, the United States experienced a shortage of 15 cancer drugs "due to manufacturing and supply chain problems", with "widely used generic drugs", cisplatin, carboplatin and methotrexate all in short duration.

According to a recent survey Directed by the American Society of Health-System Pharmacists (ASHP), more than 99% of respondents said they had suffered drug shortages, and almost 60% said that shortages of chemotherapy medication had "a critical impact" .

In her Nyt Item of opinion, Tucker noted that carboplatin and cisplatin were affected by the purchase of panic, which occurs when large hospitals try to avoid the risk of shortage and place large orders. There were also quality problems: a 2022 FDA inspection revealed bad practices in one of the manufacturing plans of intas pharmaceutical products, which encourages them to stop production, reported Fierce Pharma.

While the intas have resumed production and certain cancer centers report a Improvement of shortages , the FDA always lists drugs as being broken down, the Nyt reported today.

In relation: Mucinex is taken from the pharmacy shelves, say indignant buyers .

The United States is also fighting against a shortage of weight loss and diabetes drugs. Treatments have skyrocketed in popularity thanks to their narcotic weight loss results. But in recent times, patients have had difficulties fill their orders For the weight loss of Novo Nordisk and type 2 diabetes, Wegovy and Ozempic ( semaglutide ), respectively, as well as the treatment of diabetes of Eli Lilly Mounjaro ( shooting ), Reported CNBC.

At the end of last month, Novo Nordisk confirmed that it would be Start -up dosage kits In Europe, Reuters reported. In addition, the company said that it would reduce the supplies of Victoza, another drug on diabetes, in order to put more resources in the manufacture of Ozempic.

As MEDDSCPAE reported, the Sémaglutide shortage - the active ingredient in the Ozempic and the Wegovy - is It is unlikely that lasting forever And CNBC indicated that the offer could improve thanks to the investment strategy of Novo Nordisk. Mounjaro’s offer has also improved in the United States, said Eli Lilly in November, but it remains in a global diet, according to CNBC.

However, demand is not supposed to slow down next year - and even if analysts provide an improvement in supply constraints, CNBC noted that they thought it will be years before there was one Complete resolution.

Guggenheim analyst Seamus Fernandez said to the point of sale that supply problems are probably "the greatest" for investors in 2024.

In relation: A new very effective weight loss drug will cost 20% lower than the Ozempic .

Round the list of drug shortages likely to extend to 2024 is the Amoxicillin powder shape , a commonly prescribed antibiotic. The specific form of the shortage is used to make Liquid drugs Who are generally prescribed to children who cannot swallow pills, CNN reported. AE0FCC31AE342FD3A1346EBB1F342FCB

Amoxicillin has been in shortage since October 2022, according to the FDA, and the current problem is aggravated by an increase in cases of streptococcal throat dating from the end of the summer this year.

CNN has reported that all manufacturers of amoxicillin powder did not give reasons for the shortage, but on the FDA website, different forms of HIKMA pharmaceuticals are listed as being "in allocation". According to CNN, this means that customers can order limited quantities of the antibiotic.

"For amoxicillin powder for a oral suspension that was registered due to the increased demand last fall, the four manufacturers continue to produce, release and work to recover entirely from the shortage. We will continue to Keep the website up to date with the recovery dates planned as recovery dates planned such as recovery dates as the companies provide them and offer assistance on everything that companies need to increase the offer " said the FDA in a statement at CNN last month.

With 2024 at the corner of the street, it is unlikely that this shortage is bursting entirely before ringing in the new year.

"We still see a lot, especially amoxicillin And some of the drugs that we use a lot at the moment in the season of colds and flu, " Sara Sahl , MD, a Hartford Healthcare pediatrician based in Torrington, Connecticut, told the Hartford Current End of november. "We use them to treat ear infections and streptococcal throat infections, and basically, it is the pharmacies have come out. We receive a lot of messages that have been out of time or that the formulation is not in stock. "

In relation: For more information, register for our daily newsletter .